International Advocacy Toolkit: China

Print

Organizing Questions

  1. Which organization/s are significant sources of research funding? 

  2. What does the normal science funding/policy decision-making process look like?

  3. Which patient advocacy groups, if any, are active in the area?

  4. Are there existing national/regional organizations that work towards improving research funding/policy?

  5. How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all? 

  6. When are science funding/policy decisions made? 

  7. What kinds of opportunities exist for scientists to interact with funders and policymakers?

Which organization/s are significant sources of research funding? 

National government.

 What does the normal science funding/policy decision-making process look like?

  • Which group/committee/person within the funding/policy organization makes the decisions?

Peer review and committee evaluation.

  • What are the criteria the funding/policy organization/s use to make their decisions?

Innovation and feasibility

Which patient advocacy groups, if any, are active in the area?

There are no significant patient advocacy groups. 

Are there existing national/regional organizations that work towards improving research funding/policy?

China Association for Science and Technology and its branches.

How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all? 

Advisory committees and at public summons.

When are science funding/policy decisions made? 

Annually on a set schedule.

What kinds of opportunities exist for scientists to interact with funders and policymakers?

Being on Advisory committees.

  • Can scientists invite decision makers to their lab/institution to see their work firsthand?

Normally not.

  • Do the funding/policy organizations hold open meetings or solicit comments from the public that researchers can participate in?

Not usually.

Contributors: YAO Ke, MD (Eye Institute of Zhejiang University)